To investigate the psychiatric symptoms accompanying the early phases of Parkinson's disease (PD), we injected adult rats with 10.5 μg 6-hydroxydopamine (6-OHDA) bilaterally into the dorsal striatum. The resulting neurodegeneration led, 12 weeks after injection, to a mild (36%) reduction of striatal dopamine. We tested the behavioral response of sham and 6-OHDA-lesioned animals at different time points after injection to evaluate the onset and progression of behavioral abnormalities. The results showed that such a mild reduction of dopamine levels was associated with a decrease in anxiety-like behavior, an increase in "depression"-like behavior, and a marked change in social behavior. Learning and memory abilities were not affected. Overall...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopami...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopami...
Preclinical modeling of Parkinson's disease using 6-hydroxydopamine (6-OHDA) has been valuable in de...
Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor symptoms...
BACKGROUND: Parkinson's disease (PD) is a chronic neurodegenerative condition that is characterize...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson’s disease (PD) is a common neurodegenerative disorder, typically characterized by the pro...
Parkinson’s disease (PD) is estimated to impact nearly 10 million people globally and is estimated t...
Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor mani...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopami...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopami...
Preclinical modeling of Parkinson's disease using 6-hydroxydopamine (6-OHDA) has been valuable in de...
Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor symptoms...
BACKGROUND: Parkinson's disease (PD) is a chronic neurodegenerative condition that is characterize...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Objective: We here investigated the effect of bilateral 6-hydroxydopamine (6-OHDA) lesions, a rat mo...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson\u27s disease (PD) is classically characterized by motor symptoms; however, non-motor sympt...
Parkinson’s disease (PD) is a common neurodegenerative disorder, typically characterized by the pro...
Parkinson’s disease (PD) is estimated to impact nearly 10 million people globally and is estimated t...
Parkinson's disease (PD) is classically characterized by motor symptoms; however, non-motor mani...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopami...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopami...
Preclinical modeling of Parkinson's disease using 6-hydroxydopamine (6-OHDA) has been valuable in de...